Quantitative Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
SDJVC
CC
SIMG
RHJA
Quantitative Investment Management's LGND Position: Q3 2021 in Review
Quantitative Investment Management sold out of Ligand Pharmaceuticals (LGND) in Q3 2021, closing a stake of 7,284 shares — an estimated $596K sold.
Quantitative Investment Management first reported a position in LGND in Q1 2015 and held it in 14 quarters. The position peaked at $6.16M in Q1 2018. 207 funds tracked by Wall St. Rank hold LGND as of Q3 2021.
- Quantitative Investment Management reported no remaining Ligand Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
- Quantitative Investment Management sold 7,284 Ligand Pharmaceuticals shares in Q3 2021, an estimated $596K.
- Quantitative Investment Management first reported a position in Ligand Pharmaceuticals in Q1 2015 and held it in 14 quarters.
- Quantitative Investment Management's Ligand Pharmaceuticals position peaked at $6.16M in Q1 2018.
- 207 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2021.
Based on Quantitative Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.